Search research articles
Contact Us
Filters
Showing results (41-50 of 539) with videos related to
Page
of 54
Sort By:
Frontiers in Medicine
|
June 6, 2024
Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients
Harri Hemilä, Elizabeth Chalker
Nutrition (Burbank, Los Angeles County, Calif.)
|
July 27, 2025
Vitamin C in infectious diseases: Misrepresentation of the evidence
Harri Hemilä, Elizabeth Chalker
Life (Basel, Switzerland)
|
January 21, 2022
Bias against Vitamin C in Mainstream Medicine: Examples from Trials of Vitamin C for Infections
Harri Hemilä, Elizabeth Chalker
European Journal of Clinical Nutrition
|
February 15, 2022
Assessment of vitamin C effects on pneumonia and COVID-19 using Mendelian randomization: analysis may be misleading
Harri Hemilä, Elizabeth Chalker
European Journal of Preventive Cardiology
|
May 5, 2022
Vitamin C and the risk of cardiovascular diseases: Mendelian randomization study may be misleading
Harri Hemilä, Elizabeth Chalker
European Journal of Clinical Nutrition
|
December 20, 2022
Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial
Harri Hemilä, Elizabeth Chalker
Clinical Nutrition (Edinburgh, Scotland)
|
May 11, 2022
Vitamin C and the risk of atrial fibrillation: Mendelian randomization study may be misleading
Harri Hemilä, Elizabeth Chalker
Frontiers in Immunology
|
April 19, 2021
Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
Harri Hemilä, Elizabeth Chalker
Journal of Intensive Care
|
November 14, 2023
Concerns with the revised Japanese recommendation for administering vitamin C to septic patients
Harri Hemilä, Elizabeth Chalker
Frontiers in Medicine
|
October 4, 2024
Vitamin C for patients with sepsis?
Harri Hemilä, Elizabeth Chalker
Page
of 54
Search research articles
Search
Showing results (41-50 of 539) with videos related to
Sort By:
Page
of 54
Frontiers in Medicine
|
June 6, 2024
Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients
Harri Hemilä, Elizabeth Chalker
Nutrition (Burbank, Los Angeles County, Calif.)
|
July 27, 2025
Vitamin C in infectious diseases: Misrepresentation of the evidence
Harri Hemilä, Elizabeth Chalker
Life (Basel, Switzerland)
|
January 21, 2022
Bias against Vitamin C in Mainstream Medicine: Examples from Trials of Vitamin C for Infections
Harri Hemilä, Elizabeth Chalker
European Journal of Clinical Nutrition
|
February 15, 2022
Assessment of vitamin C effects on pneumonia and COVID-19 using Mendelian randomization: analysis may be misleading
Harri Hemilä, Elizabeth Chalker
European Journal of Preventive Cardiology
|
May 5, 2022
Vitamin C and the risk of cardiovascular diseases: Mendelian randomization study may be misleading
Harri Hemilä, Elizabeth Chalker
European Journal of Clinical Nutrition
|
December 20, 2022
Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial
Harri Hemilä, Elizabeth Chalker
Clinical Nutrition (Edinburgh, Scotland)
|
May 11, 2022
Vitamin C and the risk of atrial fibrillation: Mendelian randomization study may be misleading
Harri Hemilä, Elizabeth Chalker
Frontiers in Immunology
|
April 19, 2021
Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
Harri Hemilä, Elizabeth Chalker
Journal of Intensive Care
|
November 14, 2023
Concerns with the revised Japanese recommendation for administering vitamin C to septic patients
Harri Hemilä, Elizabeth Chalker
Frontiers in Medicine
|
October 4, 2024
Vitamin C for patients with sepsis?
Harri Hemilä, Elizabeth Chalker
Page
of 54